Cefozopran
Cefozopran[edit]
Cefozopran is a cephalosporin antibiotic used in the treatment of a variety of bacterial infections. It is classified as a fourth-generation cephalosporin and is known for its broad-spectrum activity against both Gram-positive and Gram-negative organisms.
Mechanism of Action[edit]
Cefozopran works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, which are essential for the cross-linking of the peptidoglycan layer. This inhibition leads to the weakening of the cell wall and ultimately causes bacterial cell lysis and death.
Spectrum of Activity[edit]
Cefozopran is effective against a wide range of bacteria, including:
- Staphylococcus aureus (including methicillin-resistant strains)
- Streptococcus pneumoniae
- Escherichia coli
- Klebsiella pneumoniae
- Pseudomonas aeruginosa
Its broad-spectrum activity makes it a valuable option in treating infections where the causative organism is unknown or in mixed infections.
Clinical Uses[edit]
Cefozopran is used in the treatment of various infections, such as:
- Urinary tract infections
- Respiratory tract infections
- Skin and soft tissue infections
- Intra-abdominal infections
Pharmacokinetics[edit]
Cefozopran is administered intravenously or intramuscularly. It is well-distributed throughout the body and achieves therapeutic concentrations in various tissues and fluids. The drug is primarily excreted unchanged in the urine, making it effective for urinary tract infections.
Side Effects[edit]
Common side effects of cefozopran include:
- Gastrointestinal disturbances such as nausea and diarrhea
- Allergic reactions, including rash and pruritus
- Hematological effects like neutropenia and thrombocytopenia
